I can hardly believe how poorly our priorities are set in this country.
The first phase of California's bullet train is funded with $985 million, and the whole project will cost untold billions. Alzheimer's and dementia affect practically every family and will cost us trillions in the future to treat, and yet researchers have a hard time coming up with $25 million to conduct Phase I and Phase II drug testing.
If we had thrown money at dementia research like we did the AIDS epidemic, many who are mentally incapacitated now could be reading this newspaper — along with the many HIV-positive Americans living today with low virus loads.
David Schubert's article should be a wake-up call.
My organization is a nonprofit that funds early stage research. More of this type of innovative research is urgently needed, but as Schubert points out, the money is not there.